743
Views
36
CrossRef citations to date
0
Altmetric
Review

Citicoline (Cognizin) in the treatment of cognitive impairment

&
Pages 247-251 | Published online: 18 Oct 2022

References

  • Abad-SantosFNovalbos-ReinaJGallego-SandinS2002Tratamiento del deterioro cognitivo lieve: utilidad de la citicolinaRev Neurol356758212389156
  • AgnoliABrunoGFioravantiM1986Therapeutic approach to senile memory impairment: a double-blind clinical trial with CDP-cholineWurtmanRJCorkinSGrowdonJHAlzheimer’s disease: proceedings of the fifth meeting of the International Study Group in the Pharmacology of Memory Disorders Associated with AgingBostonBirkhauser64954
  • BettiniRGoriniM2002I tempi di reazione durante il trattamento con citicolinaClin Ter1532475012400212
  • BlountPJNguyenCDMcDeavittJT2002Clinical use of cholinomimetic agents: a reviewJ Head Trauma Rehabil173142112106000
  • CavumSSavciV2004CDP.choline increases plasma ACTH and potentiates the stimulated release of GH, TSH, and LH: the cholinergic involvementFundam Clin Pharmacol185132315482372
  • CohenRABrowndykeJNMoserDJ2003Long-term citicoline (Cytidine Diphosphate Choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomesCerebrovasc Dis1619920412865605
  • ConantRSchaussAG2004Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literatureAltern Med Rev9173115005642
  • DavalosACastilloJAlvarez-SabinJ2002Oral citicoline in acute ischemic strike: an individual patient data pooling analysis of clinical trialsStroke332850712468781
  • Fernandez-MurrayJPMcMasterCR2005Glycerophosphocholine catabolism as a new route for choline formation for phosphatidylcholine synthesis by Kennedy pathwayJ Biol Chem4638290616172116
  • FioravantiMAgazzaniDD’IlarioD1991Relationship between hypertension and early indicators of cognitive declineDementia2516
  • FioravantiMDi CesareF1992Memory improvements and pharmacological treatment: a method to distinguish direct effects on memory from secondary effects due to attention improvementInt Psychogeriatr4119261391667
  • FioravantiMNaccaDGolfieriB1996The relevance of continuous blood pressure monitoring in examining the relationship of memory efficiency with blood pressure characteristicsPhysiol Behav591077848737895
  • FioravantiM2003History of symptomatic therapy in vascular dementiaInt Psychogeriatr15suppl 11778116191237
  • FioravantiMYanagiM2005Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyCochrane Database Syst Rev18CD00026915846601
  • FonluptPMartinetMPachecoH1985Effect of CDP-choline on dopamine metabolism in central nervous systemZappiaVKennedyEPNilssonBINovel biochemical, pharmacological, and clinical aspects of CDP-cholineNew YorkElsevierSci16977
  • GiovannettiTSchmidtKSGalloJL2005Everyday action in dementia: evidence for differential deficits in Alzheimer’s disease versus subcortical vascular dementiaJ Int Neuropsychol Soc12455316433943
  • GoldenZBouvierMSeldenJ2005Differential performance of Alzheimer’s and vascular dementia patients on a brief battery of neuropsychological testsInt J Neurosci11515697716223702
  • GunstadJBrickmanAMPaulRH2005Progressive morphometric and cognitive changes in vascular dementiaArch Clin Neuropsychol202294115708732
  • HanonOHaulonSLenoirH2005Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory lossStroke362193716151027
  • JellingerKA2004Pathology and pathophysiology of vascular cognitive impairment. A critical updatePanminerva Med462172615876978
  • McDanielMAMaierSFEinsteinGO2003“Brain-specific” nutrients: a memory cure?Nutrition199577514624946
  • MungasDHarveyDReedBR2005Longitudinal volumetric MRI change and rate of cognitive declineNeurology655657116116117
  • PaulRHCohenRAMoserDJ2003Clinical correlates of cognitive decline in vascular dementiaCogn Behav Neurol1640614765000
  • PriceCCJeffersonALMerinoJG2005Subcortical vascular dementia: integrating neuropsychological and neuroradiologic dataNeurology653768216087901
  • RaoAMHatcherJF2005Cytidine-5’-Diphosphocholine (CDP-choline) in stroke and other CNS disordersNeurochem Res30152315756928
  • RaoAMHatcherJFLarsenEC2006CDP-choline significantly restores the phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP-phosphocholine cytidylyltransferase after strokeJ Biol Chem28167182516380371
  • RockwoodKBlackSESongX2006Clinical and radiological subtypes of vascular cognitive impairment in a clinic-based cohort studyJ Neurol Sci24071416212979
  • SchindlerRJ2005Dementia with cerebrovascular disease: the benefits of early treatmentEur J Neurol12suppl 3172116144533
  • SecadesJJ2002CDP-choline: update and review of its pharmacology and clinical useMethods Find Exp Clin Pharmacol24Suppl 8153
  • ShenZX2004Brain cholinesterases: III. Future perspectives of AD research and clinical practiceMed Hypotheses6329830715236794
  • SpiersPAMyersDHochanadelGS1996Citicoline improves verbal memory in agingArch Neurol5344188624220
  • SweetLHPaulRHCohenRA2003Neuroimaging correlates of dementia rating scale performance at baseline and 12 month follow-up among patients with vascular dementiaJ Geriatr Psychiatry Neurol16240414653434
  • TraykovLBaudicSRaouxN2005Patterns of memory and perseverative behavior discriminate early Alzheimer’s disease from subcortical vascular dementiaJ Neurol Sci229230759
  • VinkersDJStekMLvan der MastRC2005Generalized atherosclerosis, cognitive decline and depressive symptoms in old ageNeurology651071216009894
  • WallinAMilosVSjogrenM2003Classification and subtypes of vascular dementiaInt Psychogeriatr15suppl 1273716191214
  • ZweiflerRM2002Membrane stabilizer: citicolineCurr Med Res Opin18Suppl 21417